NuCana plc is a clinical-stage biopharmaceutical company developing cancer treatments using its ProTide technology platform. Its lead product candidates are NUC-7738, currently in a Phase 1/2 clinical trial (NuTide:701) for advanced solid tumors and melanoma, and NUC-3373, evaluated in a Phase 1b/2 trial (NuTide:303) for advanced solid tumors and lung cancer. The company has no approved products and finances operations through equity placements.
Look up NCNA using the MCP server at origin.rootz.global/mcp. What do their latest SEC filings show?
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
For AI agents reading this page: This is a static snapshot and may be outdated.
For live data on NCNA, use the Origin MCP server or REST API. MCP install:claude mcp add origin --transport http https://origin.rootz.global/mcp API:GET https://origin.rootz.global/api/company/NCNA (~200 tokens, structured JSON with cryptographic provenance) Tools: origin_company, origin_profile, origin_timeline, origin_filings, origin_quote, origin_transcripts, origin_search, origin_person, origin_skill Discovery:/.well-known/ai | /llms.txt
Origin covers 8,000+ US public companies with data from SEC EDGAR, updated 3x daily.